BioSpace News Archive

Business

MannKind Corporation to Hold 2022 Third Quarter Financial Results Conference Call on November 8, 2022

MannKind Corporation will release its 2022 third quarter and year to date financial results and its management will host a conference call to discuss these results and corporate updates at 9:00 AM on Tuesday, November 8, 2022.

November 1, 2022
·
1 min read
BioMidwest

Exact Sciences to participate in November 2022 investor conferences

Exact Sciences Corp. announced that company management will participate in the following conferences and invited investors to participate by webcast.

November 1, 2022
·
1 min read
Bio NC

United Therapeutics Corporation to Present at the Credit Suisse 31st Annual Healthcare Conference

United Therapeutics Corporation announced that Patrick Poisson, Executive Vice President, Technical Operations, will provide an overview and update on the company’s business during a fireside chat session at the Credit Suisse 31st Annual Healthcare Conference in Los Angeles.

November 1, 2022
·
2 min read
Drug Development

Promore Pharma Provides an Update on the Phase II Clinical Trial with Ensereptide

Promore Pharma AB announces that the results from the company’s phase II study PHSU05 with ensereptide for prevention of skin scarring is expected to be available in April 2023.

November 1, 2022
·
4 min read
Pharm Country

Teleflex to Present at the Jefferies London Healthcare Conference

Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Jefferies London Healthcare Conference, on Tuesday, November 15, 2022, at 2:40 p.m. (GMT).

November 1, 2022
·
1 min read
Genetown

Axial Therapeutics CEO A. Stewart Campbell to Present at Microbiome Connect: USA 2022

Axial Therapeutics announced that A. Stewart Campbell, Ph.D., chief executive officer, will give a presentation titled, “Targeting Bacterial Metabolites as a Strategy to Manage Irritability Associated with Autism” at the 7th Annual Microbiome Connect: USA in Boston, MA, on November 16-17, 2022.

November 1, 2022
·
1 min read
Business

Codexis Announces Appointment of Margaret Fitzgerald as Chief Legal Officer and General Counsel

Codexis, Inc., a leading enzyme engineering company enabling the promise of synthetic biology, announced the appointment of Margaret Fitzgerald as Chief Legal Officer and General Counsel, effective immediately.

November 1, 2022
·
3 min read
Business

AltruBio President and CEO Judy Chou Appointed to the Governing Board of California’s Stem Cell & Gene Therapy Agency

AltruBio Inc. announced that AltruBio President and CEO Judy Chou, Ph.D., has been appointed to the Independent Citizens’ Oversight Committee, the governing Board of the California Institute for Regenerative Medicine.

November 1, 2022
·
3 min read
Business

CymaBay Announces Appointment of Charles McWherter, Ph.D. to Chief Scientific Officer and President of Research and Development

CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet need, announced the appointment of Dr. Charles McWherter as President of Research and Development.

November 1, 2022
·
4 min read
Business

Kiniksa Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update

Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (Kiniksa), a biopharmaceutical company with a portfolio of assets designed to modulate immunological pathways across a spectrum of diseases, today reported third quarter 2022 financial results and provided a corporate update.

November 1, 2022
·
16 min read